Australia to vote on limiting e-cig sales to pharmacies amid maelstrom of views

A vote on an alternative proposal that would limit e-cigarette sales to pharmacies is expected to take place today (26th June), after Australian officials earlier walked back proposals to move vaping to a more restrictive prescription-only model.

Experts are unsure how the vote will progress after a compromise proposal was made between the minority Labour government and the Australian Greens party to move vaping products to Schedule 3 (only permitted to be sold in pharmacies) and limit them to three flavours – tobacco, mint and menthol – rather than Schedule 4 (only permitted to be sold in pharmacies with a valid medical prescription).

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization